Author

Xuequing Zou

AstraZeneca (United Kingdom)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 1 Approach:statistical model· 1 Research Focus:variant effect prediction· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

Andrew Robert HarperiD· 1 shared Ben S. SiddersiD· 1 shared Dimitrios VitsiosiD· 1 shared Dorota MatelskaiD· 1 shared Fengyuan HuiD· 1 shared Jonathan MitchelliD· 1 shared Joshua ArmeniaiD· 1 shared Quanli WangiD· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenomics

Andrew Robert HarperORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer-driving mutations are enriched in genic regions intolerant to germline variation

Dimitrios Vitsios, Ryan S. Dhindsa, Dorota Matelska, Jonathan Mitchell, Xuequing Zou, Joshua Armenia, Fengyuan Hu, Quanli Wang, Ben S. Sidders, Andrew Robert Harper, Slavé Petrovski

The paper introduces OncMTR, a metric identifying genic regions intolerant to germline variation but enriched for cancer-driving mutations, and shows it improves genetic signal detection for hematologic malignancies.

Science Advances · Aug 26, 2022Peer-reviewedGenomics